Literature DB >> 20890626

Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration.

Giorgio Tasca1, Massimiliano Mirabella, Alfredo Berrettini, Mauro Monforte, Pietro Attilio Tonali, Enzo Ricci.   

Abstract

Mixed connective tissue disease (MCTD) is a rheumatological disease which has to be distinguished from other entities causing inflammatory myopathy. The usual clinical presentation of inflammatory myopathy associated with connective tissue disease is not different from isolated polymyositis or dermatomyositis, i.e., subacute onset of proximal weakness affecting both upper and lower girdle with high serum CK level. Here we report a patient with MCTD/myositis overlap syndrome displaying an uncommon clinical presentation and a distribution of muscle weakness involving facial, neck and arm muscles with sparing of lower limbs. We also describe the scarcity of muscle regeneration signs on the muscle biopsy with complete absence of alkaline phosphatase positivity in the endomysial and permysial connective tissue as a novel finding of this condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890626     DOI: 10.1007/s10072-010-0423-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

Review 1.  Mixed connective tissue disease.

Authors:  P J W Venables
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 2.  Mixed connective tissue disease.

Authors:  R W Hoffman; E L Greidinger
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

Review 3.  Muscle involvement in mixed connective tissue disease.

Authors:  Stephen Hall; Patrick Hanrahan
Journal:  Rheum Dis Clin North Am       Date:  2005-08       Impact factor: 2.670

4.  Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study.

Authors:  Y Hosoda; Y Suzuki; M Takano; T Tojo; M Homma
Journal:  J Rheumatol       Date:  1987-08       Impact factor: 4.666

5.  Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

Authors:  M Okawa-Takatsuji; S Aotsuka; M Fujinami; S Uwatoko; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

6.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

7.  Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration.

Authors:  A M Emslie-Smith; A G Engel
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

8.  Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.

Authors:  M A Burdt; R W Hoffman; S L Deutscher; G S Wang; J C Johnson; G C Sharp
Journal:  Arthritis Rheum       Date:  1999-05

Review 9.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

10.  MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle.

Authors:  Roberta Morosetti; Massimiliano Mirabella; Carla Gliubizzi; Aldobrando Broccolini; Luciana De Angelis; Enrico Tagliafico; Maurilio Sampaolesi; Teresa Gidaro; Manuela Papacci; Enrica Roncaglia; Sergio Rutella; Stefano Ferrari; Pietro Attilio Tonali; Enzo Ricci; Giulio Cossu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

View more
  1 in total

1.  Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy.

Authors:  Matteo Lucchini; Sara Bortolani; Mauro Monforte; Manuela Papacci; Enzo Ricci; Massimiliano Mirabella; Giorgio Tasca
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.